Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
CH0461929603
Tue, 06.05.2025
Xlife Sciences AG
Xlife Sciences AG
/ Key word(s): Alliance/Partnership
Xlife Sciences AG Announces Strategic Collaboration between Portfolio Company Firstgene Life Sciences and Hovione in the Field of Gene Therapy
06.05.2025 / 07:00 CET/CEST
Zurich, 6th of May 2025: Xlife Sciences AG («Xlife Sciences»; SIX:XLS) is proud to announce a st [ … ]
Mon, 05.05.2025
Xlife Sciences AG
Zurich, 5th of May 2025: Xlife Sciences AG («Xlife Sciences»; SIX: XLS) today published its 2024 Valuation Report, evaluating the company’s project portfolio as of December 31, 2024.
The independent consulting firm CYLAD Consulting conducted the assessment, which covers 16 project companies within Xlife Sciences’ total portfolio1. CYLAD Consulting [ … ]
Fri, 25.04.2025
Xlife Sciences AG
Zurich, 25th of April 2025: Xlife Sciences AG ("Xlife Sciences", SIX: XLS) today published its 2024 Annual Report. The past fiscal year was marked by strategically significant partnerships and technological breakthroughs within its portfolio companies.
«2024 was a successful year for Xlife Sciences in terms of technological progress within our port [ … ]
Wed, 23.04.2025
Xlife Sciences AG
The proposed transaction values VERAXA Biotech AG at USD 1.64 billion with expected gross cash proceeds up to USD 253 million held in trust by Voyager Acquisition Corp.
Zurich, 23rd of April 2025: Xlife Sciences AG («Xlife Sciences»; SIX:XLS), a leader for value development and commercialization of early-stage research projects, announces that its [ … ]